Health and Aesthetics Ltd

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)2 trials

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Eli Lilly and Company1 trial
• Pfizer1 trial

Closed trials

• Completed

  Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

  NCT04392154· Phase 3· Eli Lilly and Company· Source

• Completed

  Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

  NCT03422822· Phase 3· Pfizer· Source